Array BioPharma (ARRY) MEK Deal 'Favorable', BMO Capital Says

Go back to Array BioPharma (ARRY) MEK Deal 'Favorable', BMO Capital Says
Array Biopharma, Inc. (NASDAQ: ARRY) Delayed: 5.08 +0.27 (5.61%)
Previous Close $4.81    52 Week High $7.27 
Open $5.00    52 Week Low $2.39 
Day High $5.21    P/E N/A 
Day Low $4.98    EPS $-0.61 
Volume 4,508,468